Company Overview and News

Patanjali sales growth grinds to a halt in FY18

2018-05-18 livemint
New Delhi: Patanjali Ayurved Ltd’s scorching pace of growth, which had left rival packaged goods companies scurrying to defend their turf over the past few years, has stalled, with Baba Ramdev’s company saying sales was little changed in the year ended 31 March.

Most FMCG firms beat Street math in Q4

2018-05-16 thehindubusinessline
Priya Kansara The consumer sector is among the few in the economy on which analysts and investors have pinned high hopes for a strong financial performance in the March quarter. And not without reason, given the low base of the post-demonetisation period and better macro environment compared to other industries.

Nestle India shares vault nearly 6% as Q1 profit jumps

2018-05-11 livemint
New Delhi: Nestle India shares on Friday jumped nearly 6% after the FMCG major reported 35.98% rise in profit for the first quarter of 2018.

Nestle India hits all-time high

2018-05-11 thehindubusinessline
May 11 Nestle India today hit a record high and became the 3rd-largest consumer staples company by market capitalisation. The stock climbed as much as 7.11 per cent to an all-time high of Rs 9,619.7.

Market Update: CNX Pharma down as Sun Pharma slides 5%; telecom stocks tumble as Idea falls 12%

2018-05-11 moneycontrol
The equity market continued to trade on a positive note on Friday afternoon, with the Nifty trading 70 points up at 10,787 and the Sensex trading 215 points higher at 35,461.

Market update: Midcaps gain led by HPCL, Biocon; Idea falls 7%, Bharti Airtel sheds 4%

2018-05-11 moneycontrol
The equity market was trading on a positive note on Friday afternoon. The Nifty is up 33 points at 10,750 levels and the Sensex is trading 79 points higher, or up 0.23 percent.

Market update: 104 stocks hit new 52-week lows; PNB down 3%, Asian Paints top gainer at 5%

2018-05-11 moneycontrol
The equity market was trading on a positive note on Friday morning. The Nifty is up 22 points at 10,739 levels and the Sensex is trading 51 points higher, or 0.15 percent.

Nestle India Q1 profit up 36% at Rs424.03 crore

2018-05-10 livemint
New Delhi: FMCG major Nestle India on Thursday reported a 35.98% jump in profit at Rs424.03 crore for the first quarter ended 31 March 2018.

Nestle to add breakfast cereals to its portfolio, to bring it into Indian market

2018-05-10 moneycontrol
India’s largest pure-play food and beverages company, Nestle India, got the approval of its board to add breakfast cereals to its portfolio from the company's joint venture with Cereal Partners Worldwide (CPW), and also launch it in India, Business Standard reported.

Nestle India to launch breakfast cereals in India

2018-05-09 moneycontrol
FMCG major Nestle India today said it will launch breakfast cereals in India this year in line with its vision to introduce products rooted in nutrition and health. Nestle Breakfast Cereals' launch in India is set to intensify the competition in the segment, which is dominbated by Kellogg's, PepsiCo and homegrown Bagrry's.

BRIEF-Nestle India Approves To Add Nestlé Breakfast Cereals From CPW To Its Portfolio This Year

2018-05-09 reuters

Parag Milk buys Danone dairy factory in Haryana

2018-04-19 livemint
New Delhi: Parag Milk Foods Ltd on Thursday said it has acquired the dairy factory of Danone Foods and Beverages India Pvt. Ltd, the local entity of French dairy firm Danone SA.

Market Update: FMCG, realty space outperforms led by Godrej Properties, ITC; Infosys, ICICI most active

2018-04-18 moneycontrol
The Indian equity market was trading flat on Wednesday afternoon with the Nifty marginally up and was trading at 10,554 while the Sensex was up 26 points or 0.08 percent.

Market Update: Nifty Pharma gains led by Cipla, Divi#39;s Labs; Zee Entertainment up 2%, DHFL most active

2018-04-18 moneycontrol
The Indian equity market was trading flat on Wednesday morning with the Nifty marginally down and was trading at 10,548 while the Sensex was down 7 points.

Global markets: Sterling, metals shine brightest as risk appetite returns

2018-04-17 thehindubusinessline
The pound’s rise was its eighth in a row, coming as bets firm on another Bank of England rate hike next month, while yields on US Treasuries were at their highest in over three weeks ahead of a flurry of top Fed speakers.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...